Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders

被引：2
|
作者：
Marotta, Nicolas [1 ,2 ,3 ,4 ]
Boland, Michael J. [2 ,3 ]
Prosser, Benjamin L. [2 ,3 ,4 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA USA
[2] Univ Penn, Perelman Sch Med, Ctr Epilepsy & Neurodev Disorders ENDD, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Dept Physiol, Philadelphia, PA USA
来源：
CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE | 2024年 / 54卷 / 08期
关键词：
MOUSE MODEL; MUTATIONS; ENCEPHALOPATHY; PHENOTYPES; GENE; EPILEPSY; AUTISM;
D O I：
10.1016/j.cppeds.2024.101576
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Gene-targeted therapies for genetic neurodevelopmental disorders (NDDs) are becoming a reality. The Center for Epilepsy and Neurodevelopmental Disorders (ENDD) is currently focused on the development of therapeutics for STXBP1 and SYNGAP1 disorders. Here we review the known clinical features of these disorders, highlight the biological role of STXBP1 and SYNGAP1, and discuss our current understanding of pathogenic mechanisms and therapeutic development. Finally, we provide our perspective as scientists and parents of children with NDDs, and comment on the current challenges for both clinical and basic science endeavors.
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Developing a PPI inhibitor-based therapy for STXBP1 haploinsufficiency-associated epileptic disorders
    Hussain, Shobbir
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2014, 7
  • [22] Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses
    Clement, James P.
    Aceti, Massimiliano
    Creson, Thomas K.
    Ozkan, Emin D.
    Shi, Yulin
    Reish, Nicholas J.
    Almonte, Antoine G.
    Miller, Brooke H.
    Wiltgen, Brian J.
    Miller, Courtney A.
    Xu, Xiangmin
    Rumbaugh, Gavin
    CELL, 2012, 151 (04) : 709 - 723
  • [23] Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching
    Jennine M. Dawicki-McKenna
    Alex J. Felix
    Elisa A. Waxman
    Congsheng Cheng
    Defne A. Amado
    Paul T. Ranum
    Alexey Bogush
    Lea V. Dungan
    Jean Ann Maguire
    Alyssa L. Gagne
    Elizabeth A. Heller
    Deborah L. French
    Beverly L. Davidson
    Benjamin L. Prosser
    Nature Communications, 14
  • [24] Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching
    Dawicki-McKenna, Jennine M.
    Felix, Alex J.
    Waxman, Elisa A.
    Cheng, Congsheng
    Amado, Defne A.
    Ranum, Paul T.
    Bogush, Alexey
    Dungan, Lea V.
    Maguire, Jean Ann
    Gagne, Alyssa L.
    Heller, Elizabeth A.
    French, Deborah L.
    Davidson, Beverly L.
    Prosser, Benjamin L.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [25] Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review
    Liu, Shunli
    Wang, Liyuan
    Cai, Xiao Tang
    Zhou, Hui
    Yu, Dan
    Wang, Zhiling
    MEDICINE, 2018, 97 (18)
  • [26] Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases
    Di Meglio, Chloe
    Lesca, Gaetan
    Villeneuve, Nathalie
    Lacoste, Caroline
    Abidi, Affef
    Cacciagli, Pierre
    Altuzarra, Cecilia
    Roubertie, Agathe
    Afenjar, Alexandra
    Renaldo-Robin, Florence
    Isidor, Bertrand
    Gautier, Agnes
    Husson, Marie
    Cances, Claude
    Metreau, Julia
    Laroche, Cecile
    Chouchane, Mondher
    Ville, Dorothee
    Marignier, Stephanie
    Rougeot, Christelle
    Lebrun, Marine
    Martin, Anne de Saint
    Perez, Alexandra
    Riquet, Audrey
    Badens, Catherine
    Missirian, Chantal
    Philip, Nicole
    Chabrol, Brigitte
    Villard, Laurent
    Milh, Mathieu
    EPILEPSIA, 2015, 56 (12) : 1931 - 1940
  • [27] Delineating clinical and developmental outcomes in STXBP1-related disorders
    Xian, Julie
    Thalwitzer, Kim Marie
    Mckee, Jillian
    Sullivan, Katie Rose
    Brimble, Elise
    Fitch, Eryn
    Toib, Jonathan
    Kaufman, Michael C.
    Decampo, Danielle
    Cunningham, Kristin
    Pierce, Samuel R.
    Goss, James
    Rigby, Charlene Son
    Syrbe, Steffen
    Boland, Michael
    Prosser, Benjamin
    Fitter, Nasha
    Ruggiero, Sarah M.
    Helbig, Ingo
    BRAIN, 2023, 146 (12) : 5182 - 5197
  • [28] A clinical case of early-infantile epileptic encephalopathy caused by a de novo pathogenic variant in the STXBP1
    Anisimova, I.
    Levchenko, O.
    Semenova, N.
    Lavrov, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 945 - 946
  • [29] Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers
    Weckhuysen, Sarah
    Holmgren, Philip
    Hendrickx, Rik
    Jansen, Anna C.
    Hasaerts, Daniele
    Dielman, Charlotte
    de Bellescize, Julitta
    Boutry-Kryza, Nadia
    Lesca, Gaetan
    Von Spiczak, Sarah
    Helbig, Ingo
    Gill, Deepak
    Yendle, Simone
    Moller, Rikke S.
    Klitten, Laura
    Korff, Christian
    Godfraind, Catherine
    Van Rijckevorsel, Kenou
    De Jonghe, Peter
    Hjalgrim, Helle
    Scheffer, Ingrid E.
    Suls, Arvid
    EPILEPSIA, 2013, 54 (05) : e74 - e80
  • [30] Unveiling a de novo SYNGAP1 variant: Clinical progression and management challenges in a case of developmental and epileptic encephalopathy - A case report
    Ojeda, Norma E. de Leon
    Villalpando-Vargas, Fridha V.
    Mortola, Fabrizio A.
    de Leon, Juan C. Barrera
    Sanchez-Murguia, Tania P.
    Cisneros-Orozco, Jonathan A.
    Guerrero-Aranda, Alioth
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
12345